A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Post-Traumatic Stress Disorder

Interventions

DRUG

PF-04457845

4mg PF-04457845 tablet taken once daily for 7 days.

DRUG

Placebo

Matching placebo tablet taken once daily for 7 days.

Trial Locations (3)

Clinical and Translational Science Institute (CTSI), New York

NYU CTSI Research Pharmacy (Drug Shipment Address), New York

NYU School of Medicine, New York